The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancerMasafumi Iida, Shin‐ichi Hayashi|Oncotarget|2019Cited by 33
Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancerMariko Kimura, Shin‐ichi Hayashi|Oncotarget|2018Cited by 15